
    
      In this study the treatment group will include all patients receiving MILD, and the control
      group will include all patients receiving IPD for the treatment of LSS during the enrollment
      period. Reoperation and harms data will be studied for the MILD and IPD procedures for a
      24-month follow-up period after the index procedure using Medicare claims data. This study is
      exempt from IRB oversight (Department of Health and Human Services regulations 45 CFR 46).
    
  